Diagu is an international MedTech company based in Poland working on a solution that will help diagnose patients better, more accurately, and faster through an in-depth analysis of their laboratory test results using artificial intelligence. Diagu helps patients, doctors, healthcare clinics, individuals interested in maintaining good health, and many different segments.
The project is backed by a team of technical and medical professionals and an international board of advisors and is founded by Anna Rybka – Krysiak.

The startup has joined FasterCapital’s Raise Capital program and is raising $2M. The company is seeking funding to significantly expand the range of diseases diagnosed and the types of laboratory tests. Currently, the company has already signed several sales agreements, established relationships with a number of hospitals. The program will help the team at Diagu in reviewing the pitching materials. It will also help in promoting the project and matching it with investors who are interested in the latest MedTech ventures.

Mr. Hesham Zreik, CEO of FasterCapital, comments, “The team at Diagu is establishing a trustworthy basis of research and dedicated work to make Diagu the best solution out there. The MedTech market is an especially competitive market but it is also an ever-growing space with a huge demand for new and smart technologies. We are glad to be working with the team and are looking forward to leaving a positive impact.”